Despite a major media push to discourage the use of hydroxychloroquine (HCQ) in treating COVID-19, which President Trump had endorsed, evidence continues to mount that it does work. A new Belgian study published by major academic publisher Elsevier (Meeus et al.) adds to the evidence that HCQ saves lives. The researchers found: “Patients who did not receive HCQ had a 57% higher risk of mortality. A survival benefit in the treatment group was consistent across all age groups.” They concluded: “Treatment of COVID-19 using a combination of hydroxychloroquine plus azithromycin was safe and was associated with a statistically significant mortality benefit in the treatment of COVID-19 infection in hospitalized patients. Our findings do not support the current negative recommendations regarding this treatment.”
Share this post
Hydroxychloroquine prevents COVID deaths…
Share this post
Despite a major media push to discourage the use of hydroxychloroquine (HCQ) in treating COVID-19, which President Trump had endorsed, evidence continues to mount that it does work. A new Belgian study published by major academic publisher Elsevier (Meeus et al.) adds to the evidence that HCQ saves lives. The researchers found: “Patients who did not receive HCQ had a 57% higher risk of mortality. A survival benefit in the treatment group was consistent across all age groups.” They concluded: “Treatment of COVID-19 using a combination of hydroxychloroquine plus azithromycin was safe and was associated with a statistically significant mortality benefit in the treatment of COVID-19 infection in hospitalized patients. Our findings do not support the current negative recommendations regarding this treatment.”